$SRE — ADD 📊 | 6 MONTHS THESIS

$SRE — ADD 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $3.7B | EPS $1.28 vs $1.17 🟢 💡 Consensus modeled Q1 EPS of $1.17, underestimating the operational performance. The beat, coupled with reaffirmed FY guidance, suggests full-year estimates are too low. The market is pricing only in-line execution at ~18x forward P/E, not the potential for estimate tailwinds. 📉 Reward/risk: 1.91:1 🏢 Business Quality: 6/10 - Large, diversified utility with regulated and non-regulated operations; stable cash flows but capital-intensive and subject to regulatory risk. 📊 Valuation: fair — forward P/E of ~18x based on FY2026 adjusted EPS midpoint ($5.05) is in line with utility peer medians (17-20x) and SRE’s own recent history,... 🔮 Catalyst: Market absorption of Q1 beat and initiation of estimate revisions post-earnings 📊 Our read: ADD. Full analysis → https://stockduty.xyz/s/SRE0616

🎯 Q1 2026 | Rev $3.7B | EPS $1.28 vs $1.17 🟢